Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells

Journal of Cell Communication and Signaling

Volumn 2, Issue 1-2, 2008, Pages 49-56

  Leask, Andrew ^a   Chen, Shaoqiong ^a   Pala, Daphne ^a   Brigstock, David R ^b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

ALK5; CTGF; Hepatic fibrosis; Transcriptional regulation; Transforming growth factor

Indexed keywords

BIOLOGICAL MARKER; CARBON TETRACHLORIDE; CIS ACTING ELEMENT; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEIN ALK4; PROTEIN ALK7; PROTEIN CCN2; PROTEIN ETS 1; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL SELECTION; CONTROLLED STUDY; FLUORESCENCE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HEPATIC STELLATE CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL;

MUS;

EID: 54949124162     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-008-0029-z     Document Type: Article

References (27)

1. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A (2000) Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 275:15220-15225. doi: 10.1074/ jbc.275.20.15220
2. Ball DK, Moussad EA, Rageh MAE, Kemper SA, Brigstock DR (2003) Establishment of a recombinant expression system for connective tissue growth factor (CTGF) that models CTGF processing in utero. Reproduction 125:271-284. doi: 10.1530/rep.0.1250271
3. Blom IE, Goldschmeding R, Leask A (2002) Gene regulation of connective tissue growth factor: New targets for antifibrotic therapy? Matrix Biol 21:473-482. doi: 10.1016/S0945-053X(02)00055-0
4. Brigstock DR (1999) The connective tissue growth factor/cysteine-rich 61/ nephroblastoma overexpressed (CCN) family. Endocr Rev 20:189-206. doi: 10.1210/er.20.2.189
5. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A (2002) CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase and PKC. Kidney Int 62:1149-1159
6. Chen Y, Abraham DJ, Shi-Wen X, Pearson JD, Black CM, Lyons KM et al (2004) CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell 15:5635-5646. doi: 10.1091/ mbc.E04-06-0490
7. Chen Y, Shi-wen X, Eastwood M, Black CM, Denton CP, Leask A et al (2006) Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum 54:1309-1316. doi: 10.1002/ art.21725
8. Chen CC, Young JL, Monzon RI, Chen N, Todorović V, Lau LF (2007) Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling. EMBO J 26:1257-1267. doi: 10.1038/sj.emboj.7601596
9. Dziadzio M, Usinger W, Leask A, Abraham D, Black CM, Denton D et al (2005) N-terminal CTGF is marker of fibrosis for the connective tissue disease scleroderma. QJM 98:485-492. doi: 10.1093/qjmed/hci078
10. Gao R, Brigstock DR (2004) Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 279:8848-8855. doi: 10.1074/jbc.M313204200
11. Gao R, Ball DK, Perbal B, Brigstock DR (2004) Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/ 42 MAP kinase in primary rat hepatic stellate cells. J Hepatol 40:431-438. doi: 10.1016/j.jhep.2003.11.012
12. Gressner AM, Bachem MG (1994) Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: Liver fibrosis as a paradigm. Ann Biol Clin (Paris) 52:205-226
13. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276:10594-10601. doi: 10.1074/jbc.M010149200
14. Holmes A, Abraham DJ, Chen Y, Denton C, Shi-wen X, Black CM et al (2003) Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J Biol Chem 278:41728-41733. doi: 10.1074/jbc.M305019200
15. Iredale JPG (1992) Murphy, G. Hembry, R.M. Friedman S.L. and Arthur, M.J. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest 90:282-287. doi: 10.1172/JCI115850
16. Kennedy L, Liu S, Shi-Wen X, Chen Y, Eastwood M, Carter DE et al (2007) CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res 313:952-964. doi: 10.1016/j.yexcr.2006.12.006
17. Leask A, Abraham DJ (2006) All in the CCN family. J Cell Sci 119:4803-4810. doi: 10.1242/jcs.03270
18. Leask A, Holmes A, Black CM, Abraham DJ (2003) Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 278:13008-13015. doi: 10.1074/jbc.M210366200
19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25:402-408. doi: 10.1006/meth.2001.1262
20. Pala D, Kapoor M, Woods A (2008) Kennedy, L., Liu, S., Chen, S., Bursell, L., Lyons, K., Carter, D., Beier, F, Leask, A. FAK/src suppresses early chondrogenesis: Central role of CCN2. J Biol Chem 283:9239-9247. doi: 10.1074/jbc.M705175200
21. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V et al (1999) Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30:968-976. doi: 10.1002/ hep.510300425
22. Pickles M, Leask A (2007) Analysis of the CCN2 promoter in PANC-1 cells: regulation by ras/MEK/ERK. J. Cell Commun. Signal 1:85-90. doi: 10.1007/ s12079-007-0008-9
23. Pinzani M (1995) Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther 66:387-412. doi: 10.1016/0163-7258(94)00072-B
24. Shi-wen X, Stanton LA, Kennedy L, Pala D, Chen Y, Howat SL et al (2006) CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem 281:10715-10726. doi: 10.1074/jbc.M511343200
25. Shi-wen X, Renzoni EA, Kennedy L, Howat S, Chen Y, Pearson JD (2007) Bou-Gharios, G, Dashwood, MR, du Bois, RM, Black, CM, Denton, CP, Abraham, DJ, Leask, A. Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. Matrix Biol 26:625-632. doi: 10.1016/j.matbio.2007.06.003
26. Van Beek JP, Kennedy L, Rockel JS, Bernier SM (2006) Leask, A. The induction of CCN2 involves Ets-1. Arthritis Res Ther 8:R36. doi: 10.1186/ ar1890
27. Williams EJ (2000) Gaca, M.D. Brigstock, D.R. Arthur M.J. and Benyon R.C., Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol 32:754-761. doi: 10.1016/S0168-8278(00)80244-5